GazzaTlooks that way.i would say the negotiation could have something to do with the 'scoping study' Timing could be crucial, i.e., release it before or after the negotiations.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025